Throughout this week, the Washington Examiner’s Restoring America project will feature its latest series, “Reforming the Deep State: Reining in the Federal Bureaucracy.” We invited some of the best ...

Learn how to maintain user/data relationships with Firebase users and data from the Realtime database. I provide three different methods for commonly encountered scenarios. Dog spends days digging ...

Last week, the dating safety app Tea experienced a data breach, exposing 72,000 sensitive images containing selfies and photo IDs for account verification, as well as images from posts and messages.

The Tea app data breach has grown into an even larger leak, with the stolen data now shared on hacking forums and a second database discovered that allegedly contains 1.1 million private messages ...

Abstract: In our research work, the use of firebase database in applications running on mobile operating systems today, the use of firebase system in mobile applications of large organizations, the ...

Gaming Industry DayZ creator says Unity is accusing his studio of violating its software license based on the email addresses of two people who never worked there: 'This raises some serious questions ...

Unity Foods Ltd. engages in the procurement and crushing of multiple oil seeds. It operates through the following segments: Edible Oil, Animal Feed, Specialty Fats. The Edible Oil segment includes ...

UNITY Biotechnology, Inc. has announced that it will present data from its ASPIRE Phase 2B study on its senolytic candidate, UBX1325, targeting diabetic macular edema at the upcoming ARVO 2025 Annual ...

Google has formally entered the rapidly evolving AI-assisted development tool market with Firebase Studio, unveiled during its Cloud Next conference on April 9th. This base allows developers to use ...

Unity Biotechnology, Inc. (NASDAQ:UBX) stock plummeted on Monday after the company released results from its latest study. The Phase 2b ASPIRE clinical trial of intravitreal UBX1325 involed patients ...

UBX1325, a BCL-xL inhibitor, showed promising BCVA improvements in DME patients with prior anti-VEGF treatment failures. The trial demonstrated UBX1325's non-inferiority to aflibercept, except at ...